Differences in outcomes were significant
Nature 566 , 496502 (2019)
Heres how Aetna handles Wegovy coverage across different plans, including Medicare and PPO options
Mroz PA, Finan B, Gelfanov V, Yang B, Tschp MH, DiMarchi RD, Perez-Tilve D (2019) Optimized GIP analogs promote body weight lowering in mice through GIPR agonism not antagonism
On the other hand, the Danish Steno-2 study found that while intensive multifactorial intervention (targeting glucose, blood pressure, lipids and other risk factors) dramatically reduced cardiovascular events and mortality by approximately 50%, it showed no significant reduction in DPN (HR 1.12), suggesting that neuropathy may be more resistant to multifactorial interventions compared with other diabetic complications [62]